Tag: Hematologic Malignancies

NCCN Recommends Third COVID-19 Dose for Patients With Cancer

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Experts at the National Comprehensive Cancer Network (NCCN) have now issued...

25% of Patients With Cancer Lack Immunity Against Measles

Before the onslaught of COVID-19, researchers at the Fred Hutchinson Cancer Research Center in Seattle had another infectious disease worry: an “unprecedented” outbreak of measles....

Hypomethylating Agents in Children With Relapsed/Refractory AML

Hypomethylating agents are generally considered to be agents of choice for older adults with acute myeloid leukemia who cannot tolerate the rigors of more intensive...

Cancer in Kids May Present as Musculoskeletal Symptoms, Complicating Diagnosis

NEW YORK (Reuters Health) – Childhood cancer may present with musculoskeletal symptoms that mimic the features of rheumatic diseases, especially juvenile idiopathic arthritis (JIA), potentially...

Patients With Cancer Need Both Doses of COVID Vax

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The first report on responses to COVID-19 vaccination among patients with...

Gait Speed May Improve Treatment Decisions in Elderly With Cancer

Gait speed testing might improve decisions about treatment intensity for people 75 years or older with blood cancer, say researchers. “The additional information this simple...

COVID-19 Vaccines and Cancer Patients: 4 Things to Know

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Earlier this week, Medscape spoke with Nora Disis, MD, about vaccinating...

No Benefit From Tranexamic Acid Prophylaxis in Blood Cancers

Despite being routinely used in clinical settings, prophylactic use of tranexamic acid, an antifibrinolytic agent administered with platelet transfusions, did not reduce bleeding among patients...

EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma

The European Medicines Agency (EMA) today recommended granting conditional marketing authorization to brexucabtagene autoleucel (Tecartus), making it the first approved chimeric antigen receptor (CAR) T-cell therapy for...

Clinical Factors and Treatment Tied to COVID-19 Mortality

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Mortality in patients with COVID-19 and cancer is associated with general...

Hair Dye and Cancer Study ‘Offers Some Reassurance’

The largest study of its kind has found no positive association between personal use of permanent hair dye and the risk for most cancers and...

NBA Star in the Orlando Bubble

Editor’s Note: This transcript from the August 20 episode of the Blood & Cancer podcast has been edited for clarity. Click this link to listen...

Hepatitis Screening Now for All Patients With Cancer on Therapy

All patients with cancer who are candidates for systemic anticancer therapy should be screened for hepatitis B virus (HBV) infection prior to or at the...

Metastatic Cancer Linked to Worse Outcomes of COVID-19

What your doctor is reading on Medscape.com: APRIL 29, 2020 — Cancer type, stage, and recent treatment may affect outcomes of COVID-19...